IART · Categories · Upgrades
IART - Analyst upgrades
Integra LifeSciences Holdings Corporation (IART) analyst upgrades - real-time wire coverage filtered to Upgrades only.
Recent Upgrades for IART
- Integra upgraded by Argus with a new price targetArgus upgraded Integra from Hold to Buy and set a new price target of $25.00
- Integra upgraded by Citigroup with a new price targetCitigroup upgraded Integra from Sell to Neutral and set a new price target of $16.00
- Integra upgraded by ArgusArgus upgraded Integra from Hold to Buy
- Integra upgraded by BTIG ResearchBTIG Research upgraded Integra from Sell to Neutral
- Integra upgraded by Citigroup with a new price targetCitigroup upgraded Integra from Sell to Neutral and set a new price target of $38.00
- Integra upgraded by Wells Fargo with a new price targetWells Fargo upgraded Integra from Equal Weight to Overweight and set a new price target of $49.00 from $40.00 previously
- Integra upgraded by Jefferies with a new price targetJefferies upgraded Integra from Hold to Buy and set a new price target of $53.00 from $58.00 previously
- Integra Lifesciences upgraded by JP Morgan with a new price targetJP Morgan upgraded Integra Lifesciences from Underweight to Neutral and set a new price target of $75.00
Other IART categories
Is something on this page wrong? Request a change